This Biotech Stock Is Up 100% This Year. Why It's Soaring Again Today.
ImmunityBioImmunityBio(US:IBRX) Barrons·2026-01-16 10:52

Core Insights - The shares have experienced a continuous increase on every trading day in 2026, indicating a strong upward trend in the stock performance [1] Company Performance - The consistent rise in share prices suggests positive market sentiment and potential investor confidence in the company's future prospects [1]

ImmunityBio-This Biotech Stock Is Up 100% This Year. Why It's Soaring Again Today. - Reportify